Platform Technology
The ImmunArray technology platform offers a series of promising applications based on the detection of immunologic responses to disease. The products are designed to provide valuable information about the patient's immune system state and activity that is not currently available to the physician.
Home ABOUT US
About Us

ImmunArray Ltd. (IAL) is developing novel in-vitro diagnostic (IVD) tests, based on its iCHIP microarray technology platform. The products support a personalized medicine approach and IAL's first product family will provide tests for diagnosis, prognosis and therapeutic guidance of autoimmune diseases and for improving transplantation medicine.

aboutus_image1Founded in 2006, ImmunArray Ltd. holds an exclusive, worldwide license from the Weizmann Institute of Science for the iCHIP technology, and has a strong IP portfolio covering its methodologies and applications. The company has assembled a distinguished group of world-renowned advisors and partners, and boasts a seasoned management team with a solid track record in launching early-stage biotechnology companies

 

aboutus_image2 ImmunArray is in the process of developing its first product family of blood tests for screening, detection and monitoring of autoimmune diseases and transplant rejection. The company is currently conducting joint research in collaboration with leading medical centers in the USA, Europe and Israel, with product launch scheduled for early 2012.
 
Corporate Headquarters
2, Bergmann Street
Suite 212
Rehovot, Israel, 76705
+972-8-9365727
US Headquarters
800, East Leigh Street
Suite 15
Richmond, VA 23219
(804) 212-1516
Copyright 2010 Immunarray Pvt. Ltd. All Rights Reserved | Privacy Policy